Prostate cancer cells are exquisitely dependent on androgens and the androgen receptor (AR) for growth and survival, which explains the efficacy of androgen deprivation therapy (ADT) as a treatment strategy for advanced prostate cancer. The gene discussed is AR; the disease is prostate carcinoma.